Stay updated on SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Sign up to get notified when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.

Latest updates to the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page
- Check6 days agoChange DetectedThe web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.SummaryDifference1.0%
- Check13 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference1%
- Check20 days agoChange DetectedThe page has removed the estimated timestamps for when results were first posted and last updated, which may affect users' understanding of the timeliness of the information provided.SummaryDifference0.1%
- Check28 days agoChange DetectedThe page has been updated to reflect an increase in the number of study locations from 36 to 39, and the expected modernization of ClinicalTrials.gov data ingest has been pushed to July 2025. Additionally, there are updates regarding the treatment regimen for participants, including specific dosages of SAGE-718.SummaryDifference28%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe page has been updated to reflect the submission of results and has been revised to version 2.16.2.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
Stay in the know with updates to SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.